Aims To examine the associations between antihypertensive treatment with angiotensin-
converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs), β-blockers …

Background: Different antihypertensive drug classes may alter risk for atrial fibrillation. Some
studies suggest that drugs that interfere with the renin–angiotensin system may be favorable …

We aimed to investigate the effectiveness and safety of angiotensin-converting enzyme
inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on preventing atrial fibrillation …

Both angiotensin-receptor blockers (ARB) and angiotensin-converting enzyme inhibitors
(ACEI) have protective effects against atrial fibrillation (AF). The differences between ARB …

Background Secondary analyses of clinical trial data suggest that, compared with other
agents, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers …

Atrial fibrillation is the most frequent occurring sustained cardiac arrhythmia and it is related
to common cardiac disease conditions. Hypertension increases the risk of atrial fibrillation by …

Aims High blood pressure is known to be associated with future risk of atrial fibrillation.
Whether such risks can be reduced with antihypertensive therapy is less clear. We …

Eur J Clin Invest 2011; 41 (7): 719–733 Abstract Background There is not a general
agreement regarding antiarrhythmic effects on atrial fibrillation (AF) of angiotensin …

The inhibition of the renin‐angiotensin system has demonstrated both experimental and
clinical effects in preventing atrial fibrillation. However, there is still uncertainty about the role …

The renin-angiotensin-aldosterone system (RAAS) has emerged as an important hormonal
system in the initiation and pathogenesis of atrial fibrillation (AF). Therefore, angiotensin …